Uro ImagingArchives
Comparison of urinary bladder activity from [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in patients with prostate cancer undergoing PSMA-ligand PET/CT
Uro Imaging 1 min.
PET/CT with radiolabelled PSMA-ligands has become the mainstay of diagnostic imaging for prostate cancer. The several available PSMA tracers differ modestly with respect to their avidity for lesions, but show distinct patterns of off-target uptake and routes of excretion. We sought to compare urinary...
Non-invasive diagnosis strategy integrating PSMA PET/CT and mpMRI for patients with suspected prostate cancer: a multi-center study
Uro Imaging 1 min.
Multiparametric MRI (mpMRI) and ^68 Ga-PSMA PET/CT are widely used for prostate cancer (PCa) diagnosis but remain limited by false positives and modest specificity, particularly in distinguishing benign prostate diseases (BPDs) and clinically significant PCa (csPCa). Existing studies often rely on small,...
Developing a training for 3D transrectal multiparametric ultrasound of the prostate: a human factors engineering approach
Uro Imaging 1 min.
Three-dimensional multiparametric ultrasound (3D mpUS) shows promise for accurately diagnosing prostate cancer. However, its technical complexity presents usability challenges. Human Factor Engineering (HFE) studies the interaction between devices and users, by reducing human error, increasing productivity,...
Deuterium Metabolic Imaging of the Human Abdomen at Clinical Field Strength.
Uro Imaging 1 min.
The aim of the study was to translate abdominal deuterium metabolic imaging (DMI) to clinical field strength by optimizing the radiofrequency coil setup, the administered dose of deuterium (2H)-labeled glucose, and the data processing pipeline for quantitative characterization of DMI signals over time....
Computed tomography-based unsupervised clustering identifies clusters associated with progression free survival in clear cell renal cell carcinoma
Uro Imaging 5 min.
Clear cell renal cell carcinoma (ccRCC) accounts for approximately 70% of all primary renal neoplasms [1]. Although most patient present with localized disease and undergo surgery, nearly one-third experience recurrence [2], with about 75% of recurrence occurring within the first five years after surgery...
